Your browser doesn't support javascript.
loading
A randomised phase II study of modified FOLFIRINOX versus gemcitabine plus nab-paclitaxel for locally advanced pancreatic cancer (JCOG1407).
Ozaka, Masato; Nakachi, Kohei; Kobayashi, Satoshi; Ohba, Akihiro; Imaoka, Hiroshi; Terashima, Takeshi; Ishii, Hiroshi; Mizusawa, Junki; Katayama, Hiroshi; Kataoka, Tomoko; Okusaka, Takuji; Ikeda, Masafumi; Sasahira, Naoki; Miwa, Haruo; Mizukoshi, Eishiro; Okano, Naohiro; Mizuno, Nobumasa; Yamamoto, Tomohisa; Komatsu, Yoshito; Todaka, Akiko; Kamata, Ken; Furukawa, Masayuki; Fujimori, Nao; Katanuma, Akio; Takayama, Yukiko; Tsumura, Hidetaka; Fukuda, Haruhiko; Ueno, Makoto; Furuse, Junji.
Afiliação
  • Ozaka M; Department of Hepato-Biliary-Pancreatic Medicine, Gastroenterology Center, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan. Electronic address: masato.ozaka@jfcr.or.jp.
  • Nakachi K; Department of Medical Oncology, Tochigi Cancer Center, Utsunomiya, Japan.
  • Kobayashi S; Department of Gastroenterology, Kanagawa Cancer Center, Yokohama, Japan.
  • Ohba A; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Imaoka H; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Terashima T; Department of Gastroenterology, Kanazawa University Hospital, Kanazawa, Japan.
  • Ishii H; Clinical Research Center, Chiba Cancer Center, Chiba, Japan.
  • Mizusawa J; Japan Clinical Oncology Group Data Center/Operations Office, National Cancer Center Hospital, Tokyo, Japan.
  • Katayama H; Japan Clinical Oncology Group Data Center/Operations Office, National Cancer Center Hospital, Tokyo, Japan.
  • Kataoka T; Japan Clinical Oncology Group Data Center/Operations Office, National Cancer Center Hospital, Tokyo, Japan.
  • Okusaka T; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Ikeda M; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Sasahira N; Department of Hepato-Biliary-Pancreatic Medicine, Gastroenterology Center, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Miwa H; Department of Gastroenterology, Yokohama City University Medical Center, Yokohama, Japan.
  • Mizukoshi E; Department of Gastroenterology, Kanazawa University Hospital, Kanazawa, Japan.
  • Okano N; Department of Medical Oncology, Kyorin University Faculty of Medicine, Tokyo, Japan.
  • Mizuno N; Department of Gastroenterology, Aichi Cancer Center Hospital, Nagoya, Japan.
  • Yamamoto T; Department of Surgery, Kansai Medical University Hospital, Osaka, Japan.
  • Komatsu Y; Department of Gastroenterology, Hokkaido University Hospital, Sapporo, Japan.
  • Todaka A; Divison of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan.
  • Kamata K; Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Osaka, Japan.
  • Furukawa M; Department of Hepato-Biliary-Pancreatology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
  • Fujimori N; Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Katanuma A; Center for Gastroenterology, Teine-Keijinkai Hospital, Sapporo, Japan.
  • Takayama Y; Department of Gastroenterology, Tokyo Women's Medical University, Tokyo, Japan.
  • Tsumura H; Department of Gastroenterological Oncology, Hyogo Cancer Center, Akashi, Japan.
  • Fukuda H; Japan Clinical Oncology Group Data Center/Operations Office, National Cancer Center Hospital, Tokyo, Japan.
  • Ueno M; Department of Gastroenterology, Kanagawa Cancer Center, Yokohama, Japan.
  • Furuse J; Department of Gastroenterology, Kanagawa Cancer Center, Yokohama, Japan; Department of Medical Oncology, Kyorin University Faculty of Medicine, Tokyo, Japan.
Eur J Cancer ; 181: 135-144, 2023 03.
Article em En | MEDLINE | ID: mdl-36652891
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Gencitabina Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Gencitabina Idioma: En Ano de publicação: 2023 Tipo de documento: Article